Delivery Order SPE2DB22D2206-SPE2DB22FES54
Award Date 9/7/22
Potential Completion Date 9/28/22
Potential Value $219K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 mg/10 ml vials. The total potential value of the award is $128,918.52, with a completion date of October 15, 2021. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 MG/10 ML VIAL 10ML. The delivery order has a potential value of $109,309.50 and a completion date of March 3, 2022. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceutical products...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The delivery order, with a potential value of $131,171.40, is for 300 mg/10 ml vials of the drug OCREVUS. The order was placed against an existing contract held by Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product, with a potential value of $109,309.50 and a completion date of March 3, 2022. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract awards from DLA to supply pharmaceuticals,...
- This is a $23,118.08 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OCREVUS 300 mg/10 ml vials. The contract has a completion date of January 26, 2024. Amerisourcebergen Drug Corp, operating out of its corporate office in Conshohocken, Pennsylvania, has received numerous federal contracts from DLA to supply pharmaceuticals and medical supplies in support of military...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of pharmaceutical products. Specifically, the order is for OCREVUS 300 MG/10 ML VIAL 10ML, a specialty medication. The firm fixed price delivery order has a potential value of $196,757.10 and a completion date of August 12, 2022. No set-aside designation was used. AmerisourceBergen Drug Corp, operating out of its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ocrevus 300 mg/10 ml vials totaling $12,019.28. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of OCREVUS 300 MG/10 ML vials, with a potential value of $128,918.52 and a performance period from August 2, 2021 to August 23, 2021. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards to provide pharmaceuticals, medical supplies,...
- This is a $109,309.50 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 300 mg/10 ml vials of the pharmaceutical product OCREVUS. The delivery order was placed against an existing contract vehicle, with no set-aside designation. AmerisourceBergen Drug Corp, as the prime contractor, will provide the pharmaceutical products to support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Ocrevus 300 mg/10 ml vials with a ceiling value of $253,329.60 and an ultimate completion date of December 2, 2025. This firm fixed-price delivery order is unclassified as a set-aside contract and represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...